Skip to main content
Equibles
RZLT logo

RZLT · Rezolute, Inc. · Metrics

Track RZLT — free

Use RZLT with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research RZLT.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$3.86 -0.01 (-0.13%)
Russell 2000 member Rebalance outlook locked
Market Cap
$373.35M
Shares
96.72M
Volume · Oct 23 1.2M Avg daily vol (3M) 1.49M

RZLT metrics

62 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$3.86
Market cap
$373.35M

Price action

20 metrics
Price change (1W)
-1.0%
Price change (30D)
-4.5%
Price change (3M)
-27.3%
Price change (6M)
+24.1%
Price change (YTD)
+63.6%
Price change (1Y)
-60.7%
Trailing year
Price change (5Y)
-40.6%
52-week high
$10.94
52-week low
$1.40
Change from 52-week high
-64.7%
Change from 52-week low
+175.7%
Annualized volatility
127.7%
Annualized volatility (3M)
60.2%
Beta
1.1
RSI (14D)
42.5
Price vs SMA 50
-10.9%
Price vs SMA 200
+0.4%
Avg volume (3M)
1.50M
Relative volume
0.9
Average dollar volume
$6.67M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
96.72M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
3.6
reciprocal yield 28.1%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-21.7%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-05-20

Profitability

9 metrics
Gross margin
—
Operating margin
—
Trailing 12 months
Net margin
—
Gross profit (TTM)
—
Operating profit (TTM)
−$82.97M
Net income (TTM)
−$77.59M
Trailing 12 months
Diluted EPS (TTM)
$-0.75
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
$-0.80
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
$-0.75
Operating cash flow per diluted share (TTM)
$-0.62
Free cash flow per diluted share (TTM)
$-0.87
Capital expenditures per diluted share (TTM)
$0.00
R&D per diluted share (TTM)
$0.52
Stock compensation per diluted share (TTM)
$0.14
Book value per share
$1.04

Growth

11 metrics
Revenue growth YoY
—
Year over year
Net income growth YoY
—
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+48.6%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-77.1%
Return on assets
-68.8%
Debt / equity
—
Current ratio
9.7
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
—
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$10.62M
Total assets
$112.85M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$64.64M
Capital expenditures (TTM)
$153,000
R&D (TTM)
$53.80M
SG&A (TTM)
—
Stock compensation (TTM)
$14.46M
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
147
13F filer change QoQ
+19
Institutional ownership
92.6%
Conviction holders (share of 13F filers)
1.4%
Crowding (high-turnover and private-fund holders)
43.0%
Private-fund adviser ownership
40.0%
Active holders' share change QoQ
-3.7%
Holder tenure
8.5
Price vs estimated holder cost
-2.1%

Ownership (registered funds)

1 metrics
Index-fund ownership
11.5%

Short interest

3 metrics
Short interest
17.3%
Latest settlement · 8.9 days to cover
Days to cover
8.9d
Short-squeeze score
74 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1509261 CUSIP 76200L309 13F (30d) 13 filings 13 filers Visit website Investor relations